drugset
drugset / Trial / NCT02716688

S-1 and Radiotherapy for Elderly Esophageal Cancer Patients

NCT02716688 ↗

Phase 2 Withdrawn Zhejiang Provincial People's Hospital
NaSingle-groupOpen-labelTreatment

Summary

To investigate the efficacy and toxicity of S-1 with concurrent radiotherapy in older patients with esophageal cancer.

Timeline

Start
2016-01
Primary completion
2019-12
Completion
2020-12

Outcome

Outcome not reported

Stopped (Enrollment): “No patients enrolled.”

Drugs

EvaluationDrugModalityDoseRoute
Subject S-1 Small molecule 70 mg/m2 Oral

Indications

esophageal cancer